AstraZeneca's combo lung disease therapy fails to win FDA approval

The U.S. Food and Drug Administration declined to approve AstraZeneca Plc's combination therapy to treat smoker's lung, the drugmaker said on Tuesday.


from Reuters: Health News https://ift.tt/2o2GaKe

Comments

Popular posts from this blog

Man hit with $650K medical bill for emergency back surgery gets relief